AbbVie, Inc.
(NYSE : ABBV)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
PFEPfizer Inc. 1.14%53.070.9%$1380.41m
JNJJohnson & Johnson 1.30%179.280.7%$1370.15m
BMYBristol-Myers Squibb Co. 1.04%76.981.0%$1209.69m
MRKMerck & Co., Inc. 0.66%94.170.7%$1147.21m
ABBVAbbVie, Inc. -1.01%149.481.9%$1126.59m
LLYEli Lilly & Co. 1.39%303.021.1%$904.66m
AZNAstraZeneca Plc 0.67%66.651.0%$521.09m
BHVNBiohaven Pharmaceutical Holding Co. Ltd. 1.00%143.450.0%$463.08m
VERUVeru, Inc. -1.42%13.190.0%$314.13m
NVSNovartis AG 1.43%90.700.2%$254.79m
GSKGlaxoSmithKline Plc 0.76%44.860.2%$245.02m
HZNPHorizon Therapeutics Plc -1.85%88.685.4%$196.70m
NVONovo Nordisk A/S 0.24%108.010.1%$191.19m
SGENSeagen Inc. 0.44%140.255.7%$182.55m
VTRSViatris, Inc. -1.31%11.650.0%$164.02m

Company Profile

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.